Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 22 of 50:
12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, gamma subunit 2 PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, gamma subunit 1 PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, beta 4 subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, beta 3 subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, beta 2 subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, alpha 1F subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
calcium channel, voltage-dependent, beta 1 subunit PERGOLIDE Calcium Channel Type L, Benzothiazepine 78% 3.301uM 2.934uM View
Cytochrom P450-2C19 monooxygenase ROTENONE CYP450-2C19 Inhibition 78% 3.6486uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 BW-723C86 Adrenergic, Norepinephrine Transporter 78% 3.6257uM 3.5957uM View
Cytochrom P450-2D6 monooxygenase CYCLIZINE CYP450-2D6 Inhibition 78% 6.2175uM NoneNone View
epidermal growth factor receptor THIORIDAZINE Protein Tyrosine Kinase, EGF Receptor 78% 2.947uM NoneNone View
mitogen activated protein kinase 14 ZAFIRLUKAST Protein Serine/Threonine Kinase, p38alpha 78% .353uM NoneNone View
mitogen-activated protein kinase 14 ZAFIRLUKAST Protein Serine/Threonine Kinase, p38alpha 78% .353uM NoneNone View
cholinergic receptor, muscarinic 3 MONTELUKAST Muscarinic M3 78% 6.626uM 1.404uM View
cannabinoid receptor 1 (brain) FLUNARIZINE Cannabinoid CB1 78% 3.028uM 2.391uM View
calcium channel, voltage-dependent, gamma subunit 8 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
calcium channel, voltage-dependent, gamma subunit 7 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
calcium channel, voltage-dependent, gamma subunit 6 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
calcium channel, voltage-dependent, gamma subunit 5 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
calcium channel, voltage-dependent, gamma subunit 4 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
calcium channel, voltage-dependent, gamma subunit 3 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
calcium channel, voltage-dependent, gamma subunit 2 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
calcium channel, voltage-dependent, gamma subunit 1 DIMENHYDRINATE Calcium Channel Type L, Phenylalkylamine 78% 3.344uM 3.251uM View
sodium channel, voltage-gated, type III, beta PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PROMAZINE Sodium Channel, Site 2 77% 2.573uM 2.347uM View
5-hydroxytryptamine (serotonin) receptor 2C TERCONAZOLE Serotonin 5-HT2C 77% 6.961uM 3.646uM View
adrenergic receptor, alpha 1d (Non-specific probe) TERCONAZOLE Adrenergic alpha1D 77% 14.385uM 7.07uM View
cholinergic receptor, muscarinic 2 PROCHLORPERAZINE Muscarinic M2 77% 3.112uM 1.107uM View
A3 adenosine receptor TROGLITAZONE Adenosine A3 77% 5.208uM 2.943uM View
adrenergic receptor, alpha 1d (Non-specific probe) ECONAZOLE Adrenergic alpha1D 77% 8.897uM 4.373uM View
calcium channel, voltage-dependent, gamma subunit 8 SULCONAZOLE Calcium Channel Type L, Dihydropyridine 77% 2.427uM 1.56uM View
calcium channel, voltage-dependent, gamma subunit 7 SULCONAZOLE Calcium Channel Type L, Dihydropyridine 77% 2.427uM 1.56uM View
calcium channel, voltage-dependent, gamma subunit 6 SULCONAZOLE Calcium Channel Type L, Dihydropyridine 77% 2.427uM 1.56uM View
calcium channel, voltage-dependent, gamma subunit 5 SULCONAZOLE Calcium Channel Type L, Dihydropyridine 77% 2.427uM 1.56uM View
calcium channel, voltage-dependent, gamma subunit 4 SULCONAZOLE Calcium Channel Type L, Dihydropyridine 77% 2.427uM 1.56uM View
Protein-tyrosine kinase, Fyn BETA-NAPHTHOFLAVONE Protein Tyrosine Kinase, Fyn 77% 2.5149uM NoneNone View
epidermal growth factor receptor PERHEXILINE Protein Tyrosine Kinase, EGF Receptor 77% 1.4852uM NoneNone View
Cytochrom P450-2C19 monooxygenase BUPROPION CYP450-2C19 Inhibition 77% 1.9983uM NoneNone View
5-hydroxytryptamine receptor 6 PROPAFENONE Serotonin 5-HT6 77% 1.863uM .865uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 AMBROXOL Serotonin Transporter 77% 3.391uM 1.802uM View
Protein-tyrosine kinase, Fyn TERFENADINE Protein Tyrosine Kinase, Fyn 77% 6.123uM NoneNone View
mu-opioid receptor MOR DOMPERIDONE Opiate mu 77% 4.218uM 1.712uM View
histamine receptor H 2 IMATINIB Histamine H2 77% 1.963uM 1.93uM View
dopamine receptor D3 CYCLIZINE Dopamine D3 77% 2.992uM 1.016uM View
Cytochrom P450-2D6 monooxygenase LOPERAMIDE CYP450-2D6 Inhibition 77% 2uM NoneNone View
Cytochrom P450-2C19 monooxygenase ETHYLESTRENOL CYP450-2C19 Inhibition 77% 1.2907uM NoneNone View
Cytochrom P450-2C19 monooxygenase RAPAMYCIN CYP450-2C19 Inhibition 77% 4uM NoneNone View
Cytochrom P450-2C19 monooxygenase RESVERATROL CYP450-2C19 Inhibition 77% 3uM NoneNone View
A3 adenosine receptor HYDROXYPROGESTERONE Adenosine A3 77% 4.73uM 2.674uM View
5-hydroxytryptamine (serotonin) receptor 2A DIPHENIDOL Serotonin 5-HT2A 77% 2.586uM .739uM View
estrogen receptor 1 ETHYLESTRENOL Estrogen ERalpha 77% 1.121uM .32uM View
estrogen receptor 1 ETHYLESTRENOL Estrogen ERalpha 77% 1.121uM .32uM View
adrenergic receptor, alpha 2a MOXONIDINE Imidazoline I2, Central 77% 1.4764uM .9843uM View
adrenergic receptor, alpha 2c (Non-specific probe) MOXONIDINE Imidazoline I2, Central 77% 1.4764uM .9843uM View
Protein-tyrosine kinase, Fyn METHYLDOPA Protein Tyrosine Kinase, Fyn 77% 5.176uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, gamma subunit 7 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, gamma subunit 6 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, gamma subunit 5 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, gamma subunit 4 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, gamma subunit 3 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, gamma subunit 2 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, gamma subunit 1 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, beta 4 subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, beta 3 subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, beta 2 subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, alpha 1F subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, beta 1 subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 LISURIDE Calcium Channel Type L, Benzothiazepine 77% 3.522uM 3.131uM View
epidermal growth factor receptor TERFENADINE Protein Tyrosine Kinase, EGF Receptor 76% 3.566uM NoneNone View
epidermal growth factor receptor ZAFIRLUKAST Protein Tyrosine Kinase, EGF Receptor 76% 5.751uM NoneNone View
angiotensin 1 converting enzyme 1 IODOQUINOL Protease, Angiotensin Converting Enzyme 76% .906uM NoneNone View
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 IODOQUINOL Protease, Angiotensin Converting Enzyme 76% .906uM NoneNone View
nitric oxide synthase 3 (endothelial cell) CHLORZOXAZONE Nitric Oxide Synthase, Constitutive (cNOS) 76% 2.794uM NoneNone View
nitric oxide synthase 3, endothelial cell CHLORZOXAZONE Nitric Oxide Synthase, Constitutive (cNOS) 76% 2.794uM NoneNone View
cholinergic receptor, muscarinic 4 CINNARIZINE Muscarinic M4 76% 3.66uM .51uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ALPHA-ERGOCRYPTINE CYP450-2C9 Inhibition 76% 6uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ALPHA-ERGOCRYPTINE CYP450-2C9 Inhibition 76% 6uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) RWJ-68354 CYP450-2C9 Inhibition 76% 1uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 RWJ-68354 CYP450-2C9 Inhibition 76% 1uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) PHENYLHYDRAZINE CYP450-2C9 Inhibition 76% 6uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 PHENYLHYDRAZINE CYP450-2C9 Inhibition 76% 6uM NoneNone View
Cytochrom P450-2C19 monooxygenase NOSCAPINE CYP450-2C19 Inhibition 76% .4003uM NoneNone View
adrenergic receptor, alpha 2b BERBERINE CHLORIDE Adrenergic alpha2C 76% 2.837uM .412uM View
adrenergic receptor, alpha 2c (Non-specific probe) BERBERINE CHLORIDE Adrenergic alpha2C 76% 2.837uM .412uM View
phosphodiesterase 3B MILRINONE Phosphodiesterase PDE3 76% .9585uM NoneNone View
phosphodiesterase 3A MILRINONE Phosphodiesterase PDE3 76% .9585uM NoneNone View
melanocortin 5 receptor DIGITONIN Melanocortin MC5 76% 3.88uM 3.639uM View
sodium channel, voltage-gated, type IV, beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel associated protein 1 MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel associated protein 2 MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type III, beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type I, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type IX, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type VII, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
amiloride-sensitive cation channel 5, intestinal MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type III, beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type XI, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type I, beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type 10, alpha polypeptide MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type IV, alpha polypeptide MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type V, alpha polypeptide MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type II, beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, nonvoltage-gated 1 alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, nonvoltage-gated 1 gamma MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, nonvoltage-gated 1 beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type XI, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, nonvoltage-gated 1, gamma MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, nonvoltage-gated 1, delta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, nonvoltage-gated 1 alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type X, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type IX, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage gated, type VIII, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type VII, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type IV, beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type IV, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type III, alpha MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
sodium channel, voltage-gated, type II, beta MAPROTILINE Sodium Channel, Site 2 76% 2.572uM 2.346uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 CLEMASTINE Dopamine Transporter 89% .678uM .538uM View
adrenergic receptor, alpha 1d (Non-specific probe) CLEMASTINE Adrenergic alpha1D 89% .032uM .015uM View
5-hydroxytryptamine (serotonin) receptor 1B CLEMASTINE Serotonin 5-HT1B 89% .359uM .22uM View
calcium channel, voltage-dependent, gamma subunit 4 CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, gamma subunit 3 CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, gamma subunit 2 CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, gamma subunit 1 CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, beta 4 subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, beta 3 subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, beta 2 subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, alpha 1F subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, beta 1 subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CLEMASTINE Calcium Channel Type L, Phenylalkylamine 89% .508uM .493uM View
adrenergic receptor, alpha 2b DOMPERIDONE Adrenergic alpha2C 89% 1.011uM .147uM View
adrenergic receptor, alpha 2c (Non-specific probe) DOMPERIDONE Adrenergic alpha2C 89% 1.011uM .147uM View
cholinergic receptor, muscarinic 2 PENTAMIDINE Muscarinic M2 89% 1.425uM .507uM View
adrenergic receptor, alpha 2b EPINEPHRINE Adrenergic alpha2B 89% .869uM .397uM View
adrenergic receptor, alpha 2a METOCLOPRAMIDE Imidazoline I2, Central 89% .708uM .472uM View
adrenergic receptor, alpha 2c (Non-specific probe) METOCLOPRAMIDE Imidazoline I2, Central 89% .708uM .472uM View
calcium channel, voltage-dependent, gamma subunit 8 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, gamma subunit 7 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, gamma subunit 6 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, gamma subunit 5 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, gamma subunit 4 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, gamma subunit 3 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, gamma subunit 2 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, gamma subunit 1 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, beta 4 subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, beta 3 subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, beta 2 subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, alpha 1F subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, beta 1 subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 MICONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.788uM 3.683uM View
prostaglandin-endoperoxide synthase 1 KETOPROFEN Cyclooxygenase COX-1 89% .014uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) KETOPROFEN Cyclooxygenase COX-1 89% .014uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 ECONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.014uM 2.93uM View
calcium channel, voltage-dependent, gamma subunit 7 ECONAZOLE Calcium Channel Type L, Phenylalkylamine 89% 3.014uM 2.93uM View
amiloride-sensitive cation channel 5, intestinal PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type III, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type XI, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type I, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type V, alpha polypeptide PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type II, beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, nonvoltage-gated 1 alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, nonvoltage-gated 1 gamma PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, nonvoltage-gated 1 beta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type XI, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, nonvoltage-gated 1, gamma PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, nonvoltage-gated 1, delta PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, nonvoltage-gated 1 alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type X, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
sodium channel, voltage-gated, type IX, alpha PERGOLIDE Sodium Channel, Site 2 88% 1.728uM 1.577uM View
phosphodiesterase 4A, cAMP specific GW-1929 Phosphodiesterase PDE4 88% 7.45uM NoneNone View